Ken Griffin Merck & Co., Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,694,300 shares of MRK stock, worth $263 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,694,300
Previous 2,438,100
10.51%
Holding current value
$263 Million
Previous $302 Million
1.37%
% of portfolio
0.06%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.3 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.6 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.39 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.76 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $247B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...